	Gene	Drug Name	Mechanism of Action	Drug development phase	Algorithm	GWAS
0	CDK6	abemaciclib	CDK inhibitor	Launched	LEAN	GCST004988
1	CDK6	alvocidib	CDK inhibitor	Phase 2	LEAN	GCST004988
2	CDK6	AMG-925	CDK inhibitor|FLT3 inhibitor	Phase 1	LEAN	GCST004988
3	CDK6	apigenin	casein kinase inhibitor|cell proliferation inhibitor	Preclinical	LEAN	GCST004988
4	CDK6	AT-7519	CDK inhibitor	Phase 2	LEAN	GCST004988
5	CDK6	chrysin	breast cancer resistance protein inhibitor	Phase 1	LEAN	GCST004988
6	CDK6	fisetin	Aurora kinase inhibitor	Preclinical	LEAN	GCST004988
7	CDK6	palbociclib	CDK inhibitor	Launched	LEAN	GCST004988
8	CDK6	RGB-286638	CDK inhibitor	Phase 1	LEAN	GCST004988
9	CDK6	ribociclib	CDK inhibitor	Launched	LEAN	GCST004988
10	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	LEAN	GCST004988
11	ESR1	allylestrenol	steroidal progestin	Launched	LEAN	GCST004988
12	ESR1	AZD9496	estrogen receptor agonist	Phase 1	LEAN	GCST004988
13	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
14	ESR1	benfluralin		Phase 3	LEAN	GCST004988
15	ESR1	bisphenol-A	synthetic estrogen	Phase 1	LEAN	GCST004988
16	ESR1	bithionol	autotaxin inhibitor	Withdrawn	LEAN	GCST004988
17	ESR1	chlorotrianisene	estrogenic hormone	Launched	LEAN	GCST004988
18	ESR1	clomifene	estrogen receptor antagonist	Launched	LEAN	GCST004988
19	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	LEAN	GCST004988
20	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	LEAN	GCST004988
21	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	LEAN	GCST004988
22	ESR1	desogestrel	progesterone receptor agonist	Launched	LEAN	GCST004988
23	ESR1	dienestrol	estrogen receptor agonist	Launched	LEAN	GCST004988
24	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	LEAN	GCST004988
25	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	LEAN	GCST004988
26	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	LEAN	GCST004988
27	ESR1	equol	estrogen receptor agonist	Launched	LEAN	GCST004988
28	ESR1	erteberel	estrogen receptor agonist	Phase 2	LEAN	GCST004988
29	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	LEAN	GCST004988
30	ESR1	estradiol	estrogen receptor agonist	Launched	LEAN	GCST004988
31	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	LEAN	GCST004988
32	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	LEAN	GCST004988
33	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	LEAN	GCST004988
34	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	LEAN	GCST004988
35	ESR1	estramustine	DNA alkylating agent	Launched	LEAN	GCST004988
36	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	LEAN	GCST004988
37	ESR1	estriol	estrogen receptor agonist	Launched	LEAN	GCST004988
38	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	LEAN	GCST004988
39	ESR1	estropipate	estrogen receptor agonist	Launched	LEAN	GCST004988
40	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	LEAN	GCST004988
41	ESR1	ethynodiol-diacetate		Launched	LEAN	GCST004988
42	ESR1	etonogestrel	progesterone receptor agonist	Launched	LEAN	GCST004988
43	ESR1	fosfestrol	synthetic estrogen	Launched	LEAN	GCST004988
44	ESR1	fulvestrant	estrogen receptor antagonist	Launched	LEAN	GCST004988
45	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	LEAN	GCST004988
46	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	LEAN	GCST004988
47	ESR1	gestrinone	progesterone receptor antagonist	Launched	LEAN	GCST004988
48	ESR1	hexestrol	synthetic estrogen	Launched	LEAN	GCST004988
49	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
50	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	LEAN	GCST004988
51	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	LEAN	GCST004988
52	ESR1	mestranol	estrogen receptor agonist	Launched	LEAN	GCST004988
53	ESR1	mitotane	antineoplastic agent	Launched	LEAN	GCST004988
54	ESR1	naloxone	opioid receptor antagonist	Launched	LEAN	GCST004988
55	ESR1	norgestimate	progesterone receptor agonist	Launched	LEAN	GCST004988
56	ESR1	norgestrel	progesterone receptor agonist	Launched	LEAN	GCST004988
57	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
58	ESR1	PPT	estrogen receptor agonist	Preclinical	LEAN	GCST004988
59	ESR1	progesterone	progesterone receptor agonist	Launched	LEAN	GCST004988
60	ESR1	promestriene	estrogen receptor agonist	Launched	LEAN	GCST004988
61	ESR1	quinestrol	estrogen receptor agonist	Launched	LEAN	GCST004988
62	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
63	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	LEAN	GCST004988
64	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
65	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	LEAN	GCST004988
66	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	LEAN	GCST004988
67	ESR1	Y-134	estrogen receptor antagonist	Preclinical	LEAN	GCST004988
68	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	LEAN	GCST004988
69	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	LEAN	GCST004988
70	EGFR	AEE788	EGFR inhibitor|VEGFR inhibitor	Phase 1/Phase 2	LEAN	GCST004988
71	EGFR	afatinib	EGFR inhibitor	Launched	LEAN	GCST004988
72	EGFR	AG-490	EGFR inhibitor|JAK inhibitor	Preclinical	LEAN	GCST004988
73	EGFR	alvocidib	CDK inhibitor	Phase 2	LEAN	GCST004988
74	EGFR	AP26113	ALK tyrosine kinase receptor inhibitor	Phase 2	LEAN	GCST004988
75	EGFR	AST-1306	EGFR inhibitor	Phase 1	LEAN	GCST004988
76	EGFR	AV-412	protein tyrosine kinase inhibitor	Phase 1	LEAN	GCST004988
77	EGFR	AZD3759	EGFR inhibitor	Phase 2/Phase 3	LEAN	GCST004988
78	EGFR	AZD8931	EGFR inhibitor	Phase 2	LEAN	GCST004988
79	EGFR	AZ5104	EGFR inhibitor	Preclinical	LEAN	GCST004988
80	EGFR	BIBU-1361	EGFR inhibitor	Preclinical	LEAN	GCST004988
81	EGFR	BIBX-1382	EGFR inhibitor	Phase 1	LEAN	GCST004988
82	EGFR	BMS-599626	EGFR inhibitor|protein tyrosine kinase inhibitor	Phase 1	LEAN	GCST004988
83	EGFR	BMS-690514	EGFR inhibitor|VEGFR inhibitor	Phase 2	LEAN	GCST004988
84	EGFR	brigatinib	ALK tyrosine kinase receptor inhibitor|EGFR inhibitor	Launched	LEAN	GCST004988
85	EGFR	canertinib	EGFR inhibitor	Phase 3	LEAN	GCST004988
86	EGFR	CGP-52411	EGFR inhibitor	Preclinical	LEAN	GCST004988
87	EGFR	CGP-53353	EGFR inhibitor|PKC inhibitor	Preclinical	LEAN	GCST004988
88	EGFR	chrysophanic-acid	EGFR inhibitor	Preclinical	LEAN	GCST004988
89	EGFR	CNX-2006	EGFR inhibitor	Preclinical	LEAN	GCST004988
90	EGFR	CUDC-101	EGFR inhibitor	Phase 1	LEAN	GCST004988
91	EGFR	dacomitinib	EGFR inhibitor	Launched	LEAN	GCST004988
92	EGFR	dovitinib	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	LEAN	GCST004988
93	EGFR	EGF816	EGFR inhibitor	Phase 2	LEAN	GCST004988
94	EGFR	erbstatin-analog	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	LEAN	GCST004988
95	EGFR	erlotinib	EGFR inhibitor	Launched	LEAN	GCST004988
96	EGFR	gefitinib	EGFR inhibitor	Launched	LEAN	GCST004988
97	EGFR	GW-583340	EGFR inhibitor	Preclinical	LEAN	GCST004988
98	EGFR	HKI-357	EGFR inhibitor	Phase 1	LEAN	GCST004988
99	EGFR	icotinib	EGFR inhibitor	Launched	LEAN	GCST004988
100	EGFR	lapatinib	EGFR inhibitor	Launched	LEAN	GCST004988
101	EGFR	lidocaine	histamine receptor agonist	Launched	LEAN	GCST004988
102	EGFR	mubritinib	protein tyrosine kinase inhibitor	Phase 1	LEAN	GCST004988
103	EGFR	neratinib	EGFR inhibitor	Launched	LEAN	GCST004988
104	EGFR	olmutinib	Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor	Launched	LEAN	GCST004988
105	EGFR	orantinib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	LEAN	GCST004988
106	EGFR	OSI-420	EGFR inhibitor	Preclinical	LEAN	GCST004988
107	EGFR	osimertinib	EGFR inhibitor	Launched	LEAN	GCST004988
108	EGFR	PD-153035	EGFR inhibitor	Phase 1	LEAN	GCST004988
109	EGFR	PD-158780	EGFR inhibitor	Preclinical	LEAN	GCST004988
110	EGFR	PD-166285	SRC inhibitor	Preclinical	LEAN	GCST004988
111	EGFR	PD-168393	EGFR inhibitor	Preclinical	LEAN	GCST004988
112	EGFR	pelitinib	EGFR inhibitor	Phase 2	LEAN	GCST004988
113	EGFR	PKI-166	EGFR inhibitor	Phase 1	LEAN	GCST004988
114	EGFR	poziotinib	EGFR inhibitor	Phase 2	LEAN	GCST004988
115	EGFR	PP-121	protein tyrosine kinase inhibitor	Preclinical	LEAN	GCST004988
116	EGFR	rociletinib	EGFR inhibitor	Phase 3	LEAN	GCST004988
117	EGFR	tyrphostin-AG-1478	EGFR inhibitor	Preclinical	LEAN	GCST004988
118	EGFR	tyrphostin-AG-18	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	LEAN	GCST004988
119	EGFR	tyrphostin-AG-494	EGFR inhibitor	Preclinical	LEAN	GCST004988
120	EGFR	tyrphostin-AG-835	protein tyrosine kinase inhibitor	Preclinical	LEAN	GCST004988
121	EGFR	tyrphostin-AG-99	tyrosine kinase inhibitor	Preclinical	LEAN	GCST004988
122	EGFR	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	LEAN	GCST004988
123	EGFR	vatalanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	LEAN	GCST004988
124	EGFR	WHI-P154	JAK inhibitor	Preclinical	LEAN	GCST004988
125	EGFR	WZ-3146	EGFR inhibitor	Preclinical	LEAN	GCST004988
126	EGFR	WZ-4002	EGFR inhibitor	Preclinical	LEAN	GCST004988
127	EGFR	WZ8040	EGFR inhibitor	Preclinical	LEAN	GCST004988
128	EGFR	XL647	EGFR inhibitor|VEGFR inhibitor	Phase 3	LEAN	GCST004988
129	EGFR	ZM-306416	Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor	Preclinical	LEAN	GCST004988
130	TLR4	C34	toll-like receptor inhibitor	Preclinical	LEAN	GCST004748
131	TLR4	lauric-acid	bacterial permeability inducer	Phase 3	LEAN	GCST004748
132	TLR4	naloxone	opioid receptor antagonist	Launched	LEAN	GCST004748
133	TLR4	paclitaxel	tubulin polymerization inhibitor	Launched	LEAN	GCST004748
134	TLR4	resatorvid	toll-like receptor inhibitor	Phase 3	LEAN	GCST004748
135	TLR4	VGX-1027	tumor necrosis factor receptor antagonist	Phase 1	LEAN	GCST004748
136	CHRM3	A-987306	histamine receptor antagonist	Preclinical	LEAN	GCST007692
137	CHRM3	aceclidine	acetylcholine receptor agonist	Launched	LEAN	GCST007692
138	CHRM3	acetylcholine	acetylcholine receptor agonist	Launched	LEAN	GCST007692
139	CHRM3	aclidinium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
140	CHRM3	alcuronium	muscle relaxant	Launched	LEAN	GCST007692
141	CHRM3	amitriptyline	norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)	Launched	LEAN	GCST007692
142	CHRM3	amoxapine	norepinephrine reputake inhibitor	Launched	LEAN	GCST007692
143	CHRM3	arecaidine-propargyl-ester	acetylcholine receptor agonist	Preclinical	LEAN	GCST007692
144	CHRM3	arecoline	acetylcholine receptor agonist	Phase 1	LEAN	GCST007692
145	CHRM3	aripiprazole	serotonin receptor agonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
146	CHRM3	atropine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
147	CHRM3	atropine-oxide	acetylcholine receptor antagonist	Preclinical	LEAN	GCST007692
148	CHRM3	bethanechol	acetylcholine receptor agonist	Launched	LEAN	GCST007692
149	CHRM3	biperiden	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
150	CHRM3	brucine	glycine receptor antagonist	Preclinical	LEAN	GCST007692
151	CHRM3	carbachol	cholinergic receptor agonist	Launched	LEAN	GCST007692
152	CHRM3	cevimeline	acetylcholine receptor agonist	Launched	LEAN	GCST007692
153	CHRM3	chlorpromazine	dopamine receptor antagonist	Launched	LEAN	GCST007692
154	CHRM3	chlorprothixene	dopamine receptor antagonist	Launched	LEAN	GCST007692
155	CHRM3	clidinium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
156	CHRM3	clozapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
157	CHRM3	curcumin	cyclooxygenase inhibitor|histone acetyltransferase inhibitor|lipoxygenase inhibitor|NFkB pathway inhibitor	Launched	LEAN	GCST007692
158	CHRM3	cyproheptadine	histamine receptor antagonist	Launched	LEAN	GCST007692
159	CHRM3	darifenacin	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
160	CHRM3	DAU-5884	acetylcholine receptor antagonist	Preclinical	LEAN	GCST007692
161	CHRM3	desipramine	tricyclic antidepressant	Launched	LEAN	GCST007692
162	CHRM3	dicycloverine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
163	CHRM3	diphemanil	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
164	CHRM3	diphenidol	acetylcholine receptor agonist	Launched	LEAN	GCST007692
165	CHRM3	disopyramide	sodium channel blocker	Launched	LEAN	GCST007692
166	CHRM3	dosulepin	norepinephrine reuptake inhibitor|serotoninâ€“norepinephrine reuptake inhibitor (SNRI)|tricyclic antidepressant	Launched	LEAN	GCST007692
167	CHRM3	fesoterodine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
168	CHRM3	glycopyrrolate	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
169	CHRM3	hyoscyamine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
170	CHRM3	imidafenacin	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
171	CHRM3	imipramine	norepinephrine reputake inhibitor|serotonin reuptake inhibitor	Launched	LEAN	GCST007692
172	CHRM3	ipratropium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
173	CHRM3	isopropamide-iodide	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
174	CHRM3	itopride	dopamine receptor antagonist	Launched	LEAN	GCST007692
175	CHRM3	levomepromazine	dopamine receptor antagonist	Launched	LEAN	GCST007692
176	CHRM3	loxapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
177	CHRM3	methscopolamine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
178	CHRM3	nortriptyline	tricyclic antidepressant	Launched	LEAN	GCST007692
179	CHRM3	olanzapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
180	CHRM3	otenzepad	acetylcholine receptor antagonist	Phase 3	LEAN	GCST007692
181	CHRM3	oxotremorine-M	acetylcholine receptor agonist	Preclinical	LEAN	GCST007692
182	CHRM3	oxotremorine-sesquifumarate	cholinergic receptor agonist	Preclinical	LEAN	GCST007692
183	CHRM3	oxybutynin	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
184	CHRM3	oxyphenonium	cholinergic receptor antagonist	Launched	LEAN	GCST007692
185	CHRM3	pancuronium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
186	CHRM3	paroxetine	selective serotonin reuptake inhibitor (SSRI)	Launched	LEAN	GCST007692
187	CHRM3	pilocarpine	acetylcholine receptor agonist	Launched	LEAN	GCST007692
188	CHRM3	pipecuronium	neuromuscular blocker	Launched	LEAN	GCST007692
189	CHRM3	pirenzepine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
190	CHRM3	promazine	dopamine receptor antagonist	Launched	LEAN	GCST007692
191	CHRM3	propantheline	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
192	CHRM3	quetiapine	dopamine receptor antagonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
193	CHRM3	scopolamine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
194	CHRM3	scopolamine-N-oxide	acetylcholine receptor antagonist	Preclinical	LEAN	GCST007692
195	CHRM3	solifenacin-succinate	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
196	CHRM3	strychnine	acetylcholine receptor antagonist	Preclinical	LEAN	GCST007692
197	CHRM3	succinylcholine-chloride		Launched	LEAN	GCST007692
198	CHRM3	tarafenacin	acetylcholine receptor antagonist	Phase 2	LEAN	GCST007692
199	CHRM3	tiotropium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
200	CHRM3	tolterodine	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
201	CHRM3	trepibutone	cholinergic receptor antagonist	Launched	LEAN	GCST007692
202	CHRM3	tropicamide	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
203	CHRM3	umeclidinium	acetylcholine receptor antagonist	Launched	LEAN	GCST007692
204	CHRM3	vinburnine	adrenergic receptor antagonist	Launched	LEAN	GCST007692
205	CHRM3	vincamine	adrenergic receptor antagonist	Withdrawn	LEAN	GCST007692
206	CHRM3	xanomeline	acetylcholine receptor agonist	Phase 3	LEAN	GCST007692
207	CHRM3	zamifenacin	acetylcholine receptor antagonist	Phase 3	LEAN	GCST007692
208	CHRM3	ziprasidone	dopamine receptor antagonist|serotonin receptor antagonist	Launched	LEAN	GCST007692
209	CHRM3	4-DAMP	cholinergic receptor antagonist	Preclinical	LEAN	GCST007692
210	CHRM3	5-hydroxymethyl-tolterodine	acetylcholine receptor antagonist	Phase 1	LEAN	GCST007692
211	CHRM3	5-methylfurmethiodide	acetylcholine receptor agonist	Preclinical	LEAN	GCST007692
212	METAP2	AGM-1470	cell cycle inhibitor	Phase 2	LEAN	GCST007692
213	METAP2	fumagillin	methionine aminopeptidase inhibitor	Launched	LEAN	GCST007692
214	METAP2	L-methionine	voltage-gated calcium channel ligand	Launched	LEAN	GCST007692
215	METAP2	methionine		Launched	LEAN	GCST007692
216	METAP2	nitroxoline	cathepsin inhibitor	Launched	LEAN	GCST007692
217	METAP2	oxyquinoline	chelating agent	Launched	LEAN	GCST007692
218	METAP2	TNP-470	methionine aminopeptidase inhibitor	Phase 2	LEAN	GCST007692
219	ADORA1	A-987306	histamine receptor antagonist	Preclinical	LEAN	GCST009841
220	ADORA1	acefylline	adenosine receptor agonist	Launched	LEAN	GCST009841
221	ADORA1	adenosine	adenosine receptor agonist	Launched	LEAN	GCST009841
222	ADORA1	aminophylline	adenosine receptor antagonist	Launched	LEAN	GCST009841
223	ADORA1	BAY-60-6583	adenosine receptor agonist	Preclinical	LEAN	GCST009841
224	ADORA1	caffeine	adenosine receptor antagonist|phosphodiesterase inhibitor	Launched	LEAN	GCST009841
225	ADORA1	capadenoson	adenosine receptor agonist	Phase 2	LEAN	GCST009841
226	ADORA1	CF102	adenosine receptor agonist	Phase 2	LEAN	GCST009841
227	ADORA1	CGH2466	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
228	ADORA1	CGS-15943	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
229	ADORA1	CGS-21680	adenosine receptor agonist	Preclinical	LEAN	GCST009841
230	ADORA1	cyproterone-acetate	androgen receptor antagonist	Launched	LEAN	GCST009841
231	ADORA1	doxofylline	adenosine receptor antagonist	Launched	LEAN	GCST009841
232	ADORA1	DPCPX	adenosine receptor antagonist	Phase 1	LEAN	GCST009841
233	ADORA1	enprofylline	phosphodiesterase inhibitor	Phase 3	LEAN	GCST009841
234	ADORA1	etofylline	adenosine receptor antagonist	Launched	LEAN	GCST009841
235	ADORA1	gabapentin	calcium channel blocker	Launched	LEAN	GCST009841
236	ADORA1	GR-79236	adenosine receptor agonist	Phase 1	LEAN	GCST009841
237	ADORA1	GS-6201	adenosine receptor antagonist	Phase 1	LEAN	GCST009841
238	ADORA1	HEMADO	adenosine receptor agonist	Preclinical	LEAN	GCST009841
239	ADORA1	IB-MECA	adenosine receptor agonist	Phase 3	LEAN	GCST009841
240	ADORA1	IBMX	phosphodiesterase inhibitor	Preclinical	LEAN	GCST009841
241	ADORA1	istradefylline	adenosine receptor antagonist	Launched	LEAN	GCST009841
242	ADORA1	KW-3902	adenosine receptor antagonist	Phase 3	LEAN	GCST009841
243	ADORA1	MRS-3777	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
244	ADORA1	NECA	adenosine receptor agonist	Launched	LEAN	GCST009841
245	ADORA1	N6-cyclopentyladenosine	adenosine receptor agonist	Preclinical	LEAN	GCST009841
246	ADORA1	PD-81723	adenosine receptor agonist	Preclinical	LEAN	GCST009841
247	ADORA1	pentoxifylline	phosphodiesterase inhibitor	Launched	LEAN	GCST009841
248	ADORA1	preladenant	adenosine receptor antagonist	Phase 3	LEAN	GCST009841
249	ADORA1	PSB-11	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
250	ADORA1	PSB-1115	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
251	ADORA1	PSB-36	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
252	ADORA1	PSB-603	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
253	ADORA1	regadenoson	adenosine receptor agonist	Launched	LEAN	GCST009841
254	ADORA1	SCH-58261	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
255	ADORA1	SDZ-WAG-994	adenosine receptor agonist	Phase 2	LEAN	GCST009841
256	ADORA1	SLV-320	adenosine receptor antagonist	Phase 2	LEAN	GCST009841
257	ADORA1	tecadenoson	adenosine receptor agonist	Phase 2	LEAN	GCST009841
258	ADORA1	theobromine	phosphodiesterase inhibitor	Launched	LEAN	GCST009841
259	ADORA1	vipadenant	adenosine receptor antagonist	Phase 1	LEAN	GCST009841
260	ADORA1	ZM-241385	adenosine receptor antagonist	Preclinical	LEAN	GCST009841
261	ADORA1	2'-MeCCPA	adenosine receptor agonist	Preclinical	LEAN	GCST009841
262	ADORA1	2-chloro-N6-cyclopentyladenosine	adenosine receptor agonist	Preclinical	LEAN	GCST009841
263	ADORA1	2-chloroadenosine	adenosine receptor agonist	Preclinical	LEAN	GCST009841
264	ADORA1	5'-chloro-5'-deoxy-ENBA-(+/-)	adenosine receptor agonist	Preclinical	LEAN	GCST009841
265	ESR1	afimoxifene	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
266	ESR1	allylestrenol	steroidal progestin	Launched	SIGMOID	GCST004988
267	ESR1	AZD9496	estrogen receptor agonist	Phase 1	SIGMOID	GCST004988
268	ESR1	bazedoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
269	ESR1	benfluralin		Phase 3	SIGMOID	GCST004988
270	ESR1	bisphenol-A	synthetic estrogen	Phase 1	SIGMOID	GCST004988
271	ESR1	bithionol	autotaxin inhibitor	Withdrawn	SIGMOID	GCST004988
272	ESR1	chlorotrianisene	estrogenic hormone	Launched	SIGMOID	GCST004988
273	ESR1	clomifene	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
274	ESR1	danazol	estrogen receptor antagonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
275	ESR1	dehydroepiandrosterone	protein synthesis stimulant	Launched	SIGMOID	GCST004988
276	ESR1	dehydroepiandrosterone-sulfate	androgen receptor agonist|estrogen receptor agonist	Launched	SIGMOID	GCST004988
277	ESR1	desogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
278	ESR1	dienestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
279	ESR1	diethylstilbestrol	estrogen receptor agonist	Withdrawn	SIGMOID	GCST004988
280	ESR1	droloxifene	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
281	ESR1	endoxifen	estrogen receptor antagonist	Phase 2	SIGMOID	GCST004988
282	ESR1	equol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
283	ESR1	erteberel	estrogen receptor agonist	Phase 2	SIGMOID	GCST004988
284	ESR1	estetrol	selective estrogen receptor modulator (SERM)	Phase 3	SIGMOID	GCST004988
285	ESR1	estradiol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
286	ESR1	estradiol-acetate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
287	ESR1	estradiol-benzoate	contraceptive agent	Preclinical	SIGMOID	GCST004988
288	ESR1	estradiol-cypionate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
289	ESR1	estradiol-valerate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
290	ESR1	estramustine	DNA alkylating agent	Launched	SIGMOID	GCST004988
291	ESR1	estramustine-phosphate	DNA synthesis inhibitor|microtubule inhibitor	Launched	SIGMOID	GCST004988
292	ESR1	estriol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
293	ESR1	estrone	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
294	ESR1	estropipate	estrogen receptor agonist	Launched	SIGMOID	GCST004988
295	ESR1	ethinyl-estradiol	estrogen receptor agonist|estrogenic hormone	Launched	SIGMOID	GCST004988
296	ESR1	ethynodiol-diacetate		Launched	SIGMOID	GCST004988
297	ESR1	etonogestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
298	ESR1	fosfestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
299	ESR1	fulvestrant	estrogen receptor antagonist	Launched	SIGMOID	GCST004988
300	ESR1	GDC-0810	selective estrogen receptor destabilizer	Phase 2	SIGMOID	GCST004988
301	ESR1	genistein	tyrosine kinase inhibitor	Phase 2/Phase 3	SIGMOID	GCST004988
302	ESR1	gestrinone	progesterone receptor antagonist	Launched	SIGMOID	GCST004988
303	ESR1	hexestrol	synthetic estrogen	Launched	SIGMOID	GCST004988
304	ESR1	lasofoxifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
305	ESR1	medroxyprogesterone-acetate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
306	ESR1	melatonin	melatonin receptor agonist|nitric oxide synthase inhibitor	Launched	SIGMOID	GCST004988
307	ESR1	mestranol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
308	ESR1	mitotane	antineoplastic agent	Launched	SIGMOID	GCST004988
309	ESR1	naloxone	opioid receptor antagonist	Launched	SIGMOID	GCST004988
310	ESR1	norgestimate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
311	ESR1	norgestrel	progesterone receptor agonist	Launched	SIGMOID	GCST004988
312	ESR1	ospemifene	selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
313	ESR1	PPT	estrogen receptor agonist	Preclinical	SIGMOID	GCST004988
314	ESR1	progesterone	progesterone receptor agonist	Launched	SIGMOID	GCST004988
315	ESR1	promestriene	estrogen receptor agonist	Launched	SIGMOID	GCST004988
316	ESR1	quinestrol	estrogen receptor agonist	Launched	SIGMOID	GCST004988
317	ESR1	raloxifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
318	ESR1	SNG-1153	selective estrogen receptor modulator (SERM)	Preclinical	SIGMOID	GCST004988
319	ESR1	tamoxifen	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
320	ESR1	tibolone	androgen receptor agonist|estrogen receptor agonist|progesterone receptor agonist	Launched	SIGMOID	GCST004988
321	ESR1	toremifene	estrogen receptor antagonist|selective estrogen receptor modulator (SERM)	Launched	SIGMOID	GCST004988
322	ESR1	Y-134	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
323	ESR1	ZK-164015	estrogen receptor antagonist	Preclinical	SIGMOID	GCST004988
324	ESR1	17-hydroxyprogesterone-caproate	progesterone receptor agonist	Launched	SIGMOID	GCST004988
325	EGFR	AEE788	EGFR inhibitor|VEGFR inhibitor	Phase 1/Phase 2	SIGMOID	GCST004988
326	EGFR	afatinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
327	EGFR	AG-490	EGFR inhibitor|JAK inhibitor	Preclinical	SIGMOID	GCST004988
328	EGFR	alvocidib	CDK inhibitor	Phase 2	SIGMOID	GCST004988
329	EGFR	AP26113	ALK tyrosine kinase receptor inhibitor	Phase 2	SIGMOID	GCST004988
330	EGFR	AST-1306	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
331	EGFR	AV-412	protein tyrosine kinase inhibitor	Phase 1	SIGMOID	GCST004988
332	EGFR	AZD3759	EGFR inhibitor	Phase 2/Phase 3	SIGMOID	GCST004988
333	EGFR	AZD8931	EGFR inhibitor	Phase 2	SIGMOID	GCST004988
334	EGFR	AZ5104	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
335	EGFR	BIBU-1361	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
336	EGFR	BIBX-1382	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
337	EGFR	BMS-599626	EGFR inhibitor|protein tyrosine kinase inhibitor	Phase 1	SIGMOID	GCST004988
338	EGFR	BMS-690514	EGFR inhibitor|VEGFR inhibitor	Phase 2	SIGMOID	GCST004988
339	EGFR	brigatinib	ALK tyrosine kinase receptor inhibitor|EGFR inhibitor	Launched	SIGMOID	GCST004988
340	EGFR	canertinib	EGFR inhibitor	Phase 3	SIGMOID	GCST004988
341	EGFR	CGP-52411	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
342	EGFR	CGP-53353	EGFR inhibitor|PKC inhibitor	Preclinical	SIGMOID	GCST004988
343	EGFR	chrysophanic-acid	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
344	EGFR	CNX-2006	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
345	EGFR	CUDC-101	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
346	EGFR	dacomitinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
347	EGFR	dovitinib	EGFR inhibitor|FGFR inhibitor|FLT3 inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	SIGMOID	GCST004988
348	EGFR	EGF816	EGFR inhibitor	Phase 2	SIGMOID	GCST004988
349	EGFR	erbstatin-analog	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	SIGMOID	GCST004988
350	EGFR	erlotinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
351	EGFR	gefitinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
352	EGFR	GW-583340	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
353	EGFR	HKI-357	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
354	EGFR	icotinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
355	EGFR	lapatinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
356	EGFR	lidocaine	histamine receptor agonist	Launched	SIGMOID	GCST004988
357	EGFR	mubritinib	protein tyrosine kinase inhibitor	Phase 1	SIGMOID	GCST004988
358	EGFR	neratinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
359	EGFR	olmutinib	Bruton's tyrosine kinase (BTK) inhibitor|EGFR inhibitor	Launched	SIGMOID	GCST004988
360	EGFR	orantinib	FGFR inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	SIGMOID	GCST004988
361	EGFR	OSI-420	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
362	EGFR	osimertinib	EGFR inhibitor	Launched	SIGMOID	GCST004988
363	EGFR	PD-153035	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
364	EGFR	PD-158780	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
365	EGFR	PD-166285	SRC inhibitor	Preclinical	SIGMOID	GCST004988
366	EGFR	PD-168393	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
367	EGFR	pelitinib	EGFR inhibitor	Phase 2	SIGMOID	GCST004988
368	EGFR	PKI-166	EGFR inhibitor	Phase 1	SIGMOID	GCST004988
369	EGFR	poziotinib	EGFR inhibitor	Phase 2	SIGMOID	GCST004988
370	EGFR	PP-121	protein tyrosine kinase inhibitor	Preclinical	SIGMOID	GCST004988
371	EGFR	rociletinib	EGFR inhibitor	Phase 3	SIGMOID	GCST004988
372	EGFR	tyrphostin-AG-1478	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
373	EGFR	tyrphostin-AG-18	EGFR inhibitor|tyrosine kinase inhibitor	Preclinical	SIGMOID	GCST004988
374	EGFR	tyrphostin-AG-494	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
375	EGFR	tyrphostin-AG-835	protein tyrosine kinase inhibitor	Preclinical	SIGMOID	GCST004988
376	EGFR	tyrphostin-AG-99	tyrosine kinase inhibitor	Preclinical	SIGMOID	GCST004988
377	EGFR	vandetanib	EGFR inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor	Launched	SIGMOID	GCST004988
378	EGFR	vatalanib	KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor	Phase 3	SIGMOID	GCST004988
379	EGFR	WHI-P154	JAK inhibitor	Preclinical	SIGMOID	GCST004988
380	EGFR	WZ-3146	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
381	EGFR	WZ-4002	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
382	EGFR	WZ8040	EGFR inhibitor	Preclinical	SIGMOID	GCST004988
383	EGFR	XL647	EGFR inhibitor|VEGFR inhibitor	Phase 3	SIGMOID	GCST004988
384	EGFR	ZM-306416	Abl kinase inhibitor|SRC inhibitor|VEGFR inhibitor	Preclinical	SIGMOID	GCST004988
